Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Evogene Ltd | EVGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.745 | 05:52:10 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.745 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.4502 - 1.44 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.745 | USD |
Evogene Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 37.41M | 50.55M | - | 5.64M | -23.88M | -0.47 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Evogene News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EVGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.76 | 0.79 | 0.7315 | 0.7628155 | 34,918 | -0.015 | -1.97% |
| 1 Month | 0.715 | 0.8996 | 0.6382 | 0.7187313 | 95,786 | 0.03 | 4.20% |
| 3 Months | 0.9275 | 0.9275 | 0.612 | 0.7388769 | 85,993 | -0.1825 | -19.68% |
| 6 Months | 0.68 | 1.04 | 0.612 | 0.8329142 | 155,364 | 0.065 | 9.56% |
| 1 Year | 0.59 | 1.44 | 0.4502 | 0.9031547 | 199,941 | 0.155 | 26.27% |
| 3 Years | 3.67 | 4.10 | 0.4502 | 1.58 | 205,661 | -2.93 | -79.70% |
| 5 Years | 1.44 | 10.2386 | 0.4502 | 3.54 | 336,032 | -0.695 | -48.26% |
Evogene Description
| Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment. |
